# LP Pharmaceutical (Xiamen) Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lp-pharmaceutical-xiamen-co

- Industry: Pharmaceuticals
- Headquarters: Xiamen, China
- Website: www.lppharma.com
- Total disclosed funding: $102M
- Latest round: Series C (Aug 19, 2020)
- Investors on record: 12

## About

Established in 2012 and based in Xiamen, China, LP Pharmaceutical (Xiamen) Co., Ltd. is a pharmaceutical company which focuses on R&D, manufactures and sells of  mucosal and oral controlled release for central nervous system, digestive system, cardiovascular, cancer and AIDS.

## Funding rounds

- Series C, Aug 19, 2020, $72M — Hong Shan, China International Capital Corporation, Fujian Venture, Industrial Bank, DYEE Capital, Lapam Capital, Shenzhen Capital Real Estate Fund, Qiandao Investment Fund Management, Guigu Xiachuang Capital
- Series B, Dec 19, 2017, $30M — CMB International Asset Management, CS Capital, Feng Yuan Capital Group

## Investors

- CMB International Asset Management (https://capitalatlas.ai/funds/cmb-international-asset-management) — Series B
- CS Capital — Series B
- Feng Yuan Capital Group — Series B
- Hong Shan — Series C
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series C
- Fujian Venture (https://capitalatlas.ai/funds/fujian-venture) — Series C
- Industrial Bank — Series C
- DYEE Capital (https://capitalatlas.ai/funds/dyee-capital) — Series C
- Lapam Capital (https://capitalatlas.ai/funds/lapam-capital) — Series C
- Shenzhen Capital Real Estate Fund (https://capitalatlas.ai/funds/shenzhen-capital-real-estate-fund) — Series C
- Qiandao Investment Fund Management (https://capitalatlas.ai/funds/qiandao-investment-fund-management) — Series C
- Guigu Xiachuang Capital — Series C